Related Experiment Video
Updated: May 29, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Coronary artery disease in a large renal transplant population: implications for management
Insights
Patients with end-stage renal disease undergoing transplantation face high mortality from coronary artery disease (CAD). Anatomic diagnosis is recommended over noninvasive imaging due to poor prediction, and revascularization may improve outcomes.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Coronary artery disease (CAD) is a major cause of mortality in patients with end-stage renal disease (ESRD) post-transplantation.
- Accurate risk stratification for CAD in this population is crucial for improving long-term survival.
Purpose of the Study:
- To evaluate the diagnostic accuracy of noninvasive stress testing for coronary artery disease in ESRD patients undergoing renal transplantation.
- To compare the outcomes of different management strategies for obstructive CAD in this high-risk cohort.
Main Methods:
- Retrospective review of 1460 renal transplant recipients from 2000-2009.
- Analysis of noninvasive stress testing (n=848) and cardiac catheterization (n=357) results.
- Comparison of 5-year post-transplant mortality rates based on CAD severity and treatment strategy (medical management, percutaneous intervention, surgical intervention).
Main Results:
- Noninvasive stress testing showed abnormal results in 32.8% of patients, but cardiac catheterization revealed obstructive CAD in 59.4% of those tested.
- No significant difference in 5-year mortality between nonobstructive CAD and those requiring percutaneous or surgical intervention.
- Medically managed obstructive CAD was associated with significantly higher 5-year mortality compared to percutaneous intervention or coronary artery bypass grafting.
Conclusions:
- Noninvasive imaging is poorly predictive of coronary artery disease in renal transplant recipients.
- Anatomic diagnosis via cardiac catheterization is recommended for accurate CAD assessment in this population.
- Revascularization strategies, including percutaneous intervention and bypass grafting, may lead to improved long-term outcomes compared to medical management.
Abstract:
Coronary artery disease (CAD) accounts for approximately one-half of the sizable mortality in patients with end-stage renal disease who have undergone transplantation. The study was a retrospective review of 1460 patients who underwent renal transplantation at the Mount Sinai Medical Center from January 1, 2000 to October 31, 2009. Noninvasive stress testing was performed in 848 patients (88.1%) with 278 patients (32.8%) having abnormal results. Cardiac catheterization was performed in 357 patients (37.1%) and of these, 212 patients had obstructive disease (59.4%). At 5 years posttransplant, there was no statistically significant difference between those with nonobstructive CAD and those who required percutaneous or surgical interventions (adjusted hazard ratio [aHR], 1.243; CI 95%, 0.513-3.010; p = 0.630). Those with medically managed obstructive CAD had significantly higher rates of death at the 5-year period when compared to those who received percutaneous intervention (aHR, 3.792; CI 95%, 1.320-10.895; p = 0.013) or those who received coronary artery bypass grafting (aHR, 6.691; CI 95%, 1.200-37.323). Because noninvasive imaging is poorly predictive of coronary disease in this high-risk population, an anatomic diagnosis is recommended. Revascularization may result in improved long-term outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
